FIGURE

Figure 1

ID

ZDB-FIG-231011-1

Publication

Ernst et al., 2023 - Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform

Other Figures

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

All Figure Page

Back to All Figure Page

Figure 1

Overview of drugs included in zebrafish cardiovascular and behavioral screening setup. (a) Information on type of candidate drugs used. All primary drug indications are listed and a set of anti-infective agents is shown. (b) A representative table of drugs that are FDA-approved or in III Clinical trial with the indicated C_max blood concentrations and risk during pregnancy.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Sci. Rep.